يعرض 1 - 10 نتائج من 45 نتيجة بحث عن '"ÖZTÜRK, SİNAN"', وقت الاستعلام: 0.80s تنقيح النتائج
  1. 1
    دورية أكاديمية
  2. 2
    دورية أكاديمية

    وصف الملف: application/pdf

    العلاقة: Rheumatology International; Makale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanı; Mert, A., Vahaboğlu, H., Arslan, F., Batirel, A., Saraçoğlu, K. T., Baştuğ, A. . Gül, A. (2022). Tocilizumab treatment in severe COVID-19: A multicenter retrospective study with matched controls. Rheumatology International, 42(3), 457-467. https://dx.doi.org/10.1007/s00296-021-04965-6Test; https://dx.doi.org/10.1007/s00296-021-04965-6Test; https://hdl.handle.net/20.500.12511/10328Test; 42; 457; 467; Q3; 000695386300001; 2-s2.0-85114767140; Q2

  3. 3
    دورية أكاديمية

    وصف الملف: application/pdf

    العلاقة: Turkish Journal of Gastroenterology; Makale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanı; Demirtürk, N., Aygen, B., Çelik, İ., Mıstık, R., Akhan, S. ve Barut, S. (2021). Real-world data from Turkey: Is sofosbuvir/ledipasvir with or without ribavirin treatment for chronic Hepatitis C really effective?. Turkish Journal of Gastroenterology, 32(2), 155-163. https://doi.org/10.5152/tjg.2020.19569Test; https://www.turkjgastroenterol.org/en/real-world-data-from-turkey-is-sofosbuvir-ledipasvir-with-or-without-ribavirin-treatment-for-chronic-hepatitis-c-really-effective-136736Test; https://hdl.handle.net/11468/10264Test; 32; 155; 163; WOS:000648816400007; 2-s2.0-85106497950; https://search.trdizin.gov.tr/yayin/detay/511870Test; Q3; Q4

  4. 4
    دورية أكاديمية
  5. 5
    دورية أكاديمية
  6. 6
    دورية أكاديمية
  7. 7
    دورية أكاديمية

    وصف الملف: application/pdf

    العلاقة: Turkish Journal of Gastroenterology; Makale - Ulusal Hakemli Dergi - Kurum Öğretim Elemanı; Aygen, B., Demirtürk, N., Yıldız, O., Çelen, M. K., Çelik, İ., Barut, Ş. ve diğerleri. (2020). Real-world efficacy, safety, and clinical outcomes of ombitasvir/paritaprevir/ritonavir ± dasabuvir ± ribavirin combination therapy in patients with hepatitis C virus genotype 1 or 4 infection: The Turkey experience experience. Turkish Journal of Gastroenterology, 31(4), 305-317.; https://www.turkjgastroenterol.org/en/real-world-efficacy-safety-and-clinical-outcomes-of-ombitasvir-paritaprevir-ritonavir-dasabuvir-ribavirin-combination-therapy-in-patients-with-hepatitis-c-virus-genotype-1-or-4-infection-the-turkey-experience-experience-136659Test; https://hdl.handle.net/11468/7219Test; 31; 305; 317; WOS:000535263200004; 2-s2.0-85084787334; https://search.trdizin.gov.tr/yayin/detay/419482Test; Q3; Q4

  8. 8
    دورية أكاديمية
  9. 9
    مؤتمر
  10. 10
    دورية أكاديمية